Home About Us Services Markets Resarch Online Trading Back Office Contact Us Download
Neuland Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs
 BSE Code
 524558
ISIN Demat
INE794A01010
Book Value
877.910003
Mar.Cap(Rs.Cr)
9,437.86
P/E
29.82
Face Value
10
Go
Your are on :   Markets   |  Company Profile   |  Key Financial Ratios
   YearsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debt-Equity Ratio0.200.260.300.350.44
Long Term Debt-Equity Ratio0.100.130.120.100.14
Current Ratio1.431.301.241.241.21
Fixed Assets1.251.071.181.131.19
Inventory4.383.714.013.703.63
Debtors4.004.214.604.313.73
Interest Cover Ratio17.477.066.153.432.27
PBIDTM (%)23.5915.1715.9813.819.20
PBITM (%)19.1610.0111.749.715.32
PBDTM (%)22.5013.7514.0710.986.85
CPM (%)18.1211.8411.766.186.30
APATM (%)13.696.687.522.082.42
ROCE (%)20.649.2411.127.553.81
RONW (%)17.907.869.492.272.59
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226  |  LALKAR COMMODITIES PVT. LTD.: MCX: 10685 FMC: MCX/TCM/CORP/0655 | NSEL: 11300 | NCDEX: 1130 FMC No : NCDEX/TCM/CORP/1106
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)